Xenetic Biosciences XBIO
NASDAQ XBIO
$2.24 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Xenetic Biosciences (XBIO) Change in Account Payables (2011 - 2013)

Updated

Xenetic Biosciences' Change in Account Payables came in at $239,026 for FY2013, up 30.4% from $183,293 in FY2012.

Analysis

Xenetic Biosciences (XBIO) Change in Account Payables (2011 - 2013) Analysis & Trends

  • Per Business Quant, earlier years put Change in Account Payables at $183,293 in FY2012 and $7,923 in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -70.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 18.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Xenetic Biosciences 5.25 Mn -20.58 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Nov 30, 2013 -121,055.00
Aug 31, 2013 282,235.00
May 31, 2013 17,147.00
Feb 28, 2013 60,699.00
Nov 30, 2012 38,933.00
Aug 31, 2012 60,426.00
May 31, 2012 53,443.00
Feb 29, 2012 30,491.00
Nov 30, 2011 17,138.00
API Access

Xenetic Biosciences Change in Account Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=XBIO&period=max&api_key=YOUR_API_KEY